Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
avian influenza
Pharma
Canada buys an initial 500K bird flu vaccine doses from GSK
Canada's public health agency has leveraged an existing deal with GSK to buy an initial 500,000 doses of the company's bird flu vaccine.
Fraiser Kansteiner
Feb 20, 2025 2:00pm
BARDA signs on with CSL Seqirus for 4.8M bird flu shots
May 30, 2024 2:32pm
CSL Seqirus to trial avian vaccine candidate in $30M BARDA deal
Oct 10, 2022 10:39am
Daiichi Sankyo comes up far short in avian flu vaccine effort
May 22, 2019 10:19am
HKEX, Zai Lab, WuXi and more—FiercePharmaAsia
Aug 31, 2018 9:05am
China has withheld deadly bird flu samples from U.S.: NYT
Aug 28, 2018 11:53am
